Welcome to
Allurion’s
Newsroom

Filter by language : AR / EN / ES / FR / IT
February 7, 2018

Allurion initiates ENLIGHTEN trial for Elipse Balloon

BARIATRIC NEWS – Allurion Technologies has started the ENLIGHTEN clinical trial for the Elipse Balloon – the world’s first and only procedureless gastric balloon for weight loss. ENLIGHTEN is a randomised, sham-controlled study designed to evaluate the safety and efficacy of the Elipse Balloon in 400 individuals. The study will be conducted at up to 12 sites in the US.

February 6, 2018

Allurion Technologies Commences Landmark Pivotal U.S. Clinical Trial for the Elipse® Balloon

BUSINESSWIRE – First Patients Treated in the U.S. with the World’s First and Only Procedureless™ Gastric Balloon for Weight Loss

December 11, 2017

FierceMedTech’s 2017 Fierce 15

FIERCE MEDICAL DEVICES – When we were compiling this year’s crop of Fierce 15 companies, some clear themes stood out. Genomics. Bioelectronics. Artificial intelligence. But while multiple companies are working to improve the use of these technologies, there runs a deeper current: making care more accessible.

For example, Allurion Technologies is developing a weight-loss balloon that is swallowed in an outpatient procedure and is naturally passed from the body at the end of the treatment period.

October 17, 2017

Allurion Technologies Appoints Four Distinguished Board Members; Secures Term Loan from Silicon Valley Bank

BUSINESS WIRE – Allurion Technologies, maker of the Elipse® Balloon – the world’s first and only procedureless™ gastric balloon for weight loss – announces the appointment of Michael Davin, Gail Zauder, Todd Zavodnick and Krishna Gupta to its Board of Directors.

July 12, 2017

The Bloomberg Baystate Business Hour: Balloons and Robots

BLOOMBERG – Bloomberg Boston Bureau Chief Tom Moroney and Radio News Anchor Anne Mostue are joined by top names from local business and finance to medicine and politics, along with Bloomberg reporters covering the latest stories in and around Boston.

July 11, 2017

Allurion Raises $27 Million for Weight-Loss Tech

WSJ – Startup’s balloon-based system delivers weight loss without surgery

July 11, 2017

This Company Raised $27 Million for a Weight Loss Balloon You Can Swallow in a Pill

FORTUNE – Beyond diet and exercise, Americans who need to lose significant weight—whether to guard against diabetes, heart disease, or other obesity-related illnesses—don’t have a lot of ideal options. Bariatric surgery is invasive, risky, and expensive.

May 18, 2017

Swallowable gastric balloon could help the obese lose weight without surgery

THE GUARDIAN – Although not a replacement for bariatric surgery, temporary balloon could be used as early intervention or for those who do not want, or cannot have, surgery

April 7, 2017

VIDEO – Allurion co-founder Shantanu Gaur presents at SAGES 2016

March 31, 2017

Allurion Repays Massachusetts Life Sciences Center

MLSC – The Massachusetts Life Sciences Center (MLSC) and Natick-based Allurion Technologies announced that the company, which was awarded a $750,000 Accelerator loan from the MLSC in 2011, has repaid the loan with interest after a successful funding round from private investors.